Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)
Launched by MCMASTER UNIVERSITY · Sep 6, 2005
Trial Information
Current as of June 06, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female
- • At least 18 years of age
- • Symptomatic for unprovoked venous thromboembolism (deep vein thrombosis \[DVT\] or pulmonary embolism \[PE\])
- • At least one pregnancy not terminated intentionally
- Exclusion Criteria:
- • Previous VTE in patients with current VTE excluded
About Mcmaster University
McMaster University, a leading research institution located in Hamilton, Ontario, Canada, is renowned for its innovative approach to education and its commitment to advancing healthcare through rigorous clinical research. The university's diverse research programs are supported by a multidisciplinary team of experts dedicated to improving patient outcomes and public health. With a strong emphasis on evidence-based medicine, McMaster University actively engages in clinical trials that explore new therapies, interventions, and health technologies, fostering collaboration among researchers, healthcare professionals, and industry partners to translate findings into real-world applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hamilton, Ontario, Canada
Hamilton, Ontario, Canada
Hamilton, Ontario, Canada
Clayton, Victoria, Australia
Hamilton, Ontario, Canada
Patients applied
Trial Officials
Huyen Tran, M.D.
Study Chair
McMaster University; Department of Medicine
Jeffrey Ginsberg, M.D.
Principal Investigator
McMaster University; Department of Medicine
Clive Kearon, M.D.
Principal Investigator
McMaster University; Department of Medicine
Jim Julian, M.Math
Principal Investigator
McMaster University; Dept. of Clinical Epidemiology & Biostatistics
Val Mueller, M.D.
Principal Investigator
McMaster University; Division of Obstetrics and Gynecology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials